| Model Number |
620RG31 |
| Medical Device Problem Codes |
Adverse Event Without Identified Device or Use Problem (2993); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Mitral Valve Insufficiency/ Regurgitation (4451); Insufficient Information (4580)
|
| Date of Event |
01/20/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during the implant of this 31mm mitral annuloplasty ring, it was explanted and replaced with a 31mm mitral bioprosthetic valve.The reason for the replacement was not reported.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Event was incorrectly assessed as reportable when the initial regulatory report was sent.Per correction there is no evidence to suggest the device caused or contributed to a death or serious injury.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during the implant of this 31mm mitral annuloplasty ring, it was explanted and replaced with a 31mm mitral bioprosthetic valve.The reason for the replacement was not reported.No additional adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
It was reported that during the implant of this 31mm mitral annuloplasty ring, it was explanted and replaced with a 31mm mitral bioprosthetic valve.The reason for the replacement was not reported.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Event was incorrectly assessed as reportable when the initial regulatory report was sent.Per correction there is no evidence to suggest the device caused or contributed to a death or serious injury.Aware date was corrected to march 11, 2026.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: a.4: weight in lbs: b.1: adv evnt/prod prob: b.2: outcome attributed to adverse event b.5: event description b.7: relevant history h.6: coding.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during the implant of this 31mm mitral annuloplasty ring, it was explanted and replaced with a 31mm mitral bioprosthetic valve.The reason for the replacement was reported as after implant, a moderate mitral regurgitant jet was discovered.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|